ChemoCentryx
CCXI
#3641
Rank
NZ$6.51 B
Marketcap
NZ$90.52
Share price
0.00%
Change (1 day)
30.56%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: NZ$6.51 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.51 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
NZ$41.99 B 545.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$659.58 B 10,031.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$169.67 B 2,506.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
NZ$195.86 B 2,908.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$917.22 B 13,989.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$309.76 B 4,658.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$253.91 B 3,800.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$63.44 B 874.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
NZ$473.28 B 7,170.02%๐Ÿ‡บ๐Ÿ‡ธ USA